Athenex Announces Xiangxue Life Sciences Receives IND Allowance from China’s National Medical Products Administration for Cancer Immunotherapy Drug Candidate

NEXT STORY
Global Pharmaceutical Drug Delivery Market Forecast to 2023: Rising Prevalence of Chronic Diseases / Growth in the Biologics Market / Technological Advancements and New Product Launches
PREV STORY
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Microbiomes Market Insights & Forecast Report 2020: Market is Forecast to Reach US$9,376 Million in 2024, Growing at a CAGR of 135.47% During 2018-2024

author_avatar
NASDAQ Market News

Novartis and UC Berkeley collaborate to tackle ‘undruggable’ disease targets

Collaboration aims to unlock difficult drug targets and accelerate the discovery of new medicines ...

author_avatar
NASDAQ Market News

Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

SEL-212 Severe Gout Program on Track; Additional Phase 2 Data for Higher Dose Cohorts ...

author_avatar
NASDAQ Market News